GnRHR2: Unraveling The Role of A G Protein-Coupled Receptor in Sexual Function and Cancer

Target Name: GNRHR2

NCBI ID: G114814

GNRHR2

Other Name(s): gonadotropin releasing hormone receptor 2 (pseudogene) | GNRHR2 variant 1 | GnRH-II-R | Gonadotropin releasing hormone receptor 2 (pseudogene), transcript variant 1

GnRHR2: Unraveling The Role of A G Protein-Coupled Receptor in Sexual Function and Cancer

Gonadotropin-releasing hormone (GnRH) is a protein that plays a crucial role in regulating sexual function and fertility in both humans and animals. GnRH is a G protein-coupled receptor that is expressed in various tissues throughout the body, including the brain, pancreas , and tests. GnRH has been implicated in the development and maintenance of sexual function, and is often studied as a potential drug target for various neurological and psychiatric disorders.

GnRHR2 is a pseudogene that was identified as a GnRH receptor subtype in the brain. GnRHR2 is a 160 amino acid protein that is expressed in the brain and is responsible for transmitting signals from the GnRH neurons to the GnRHR2 receptor, which is a G protein- coupled receptor that is expressed in the target tissues. GnRHR2 is characterized by a long N-terminus that is involved in its interactions with the GnRHR2 receptor.

GnRHR2 has been shown to play a role in several important physiological processes in the brain, including sexual function, anxiety, and depression. For example, GnRHR2 has been shown to be involved in the regulation of sexual behavior in both humans and animals. GnRHR2 neurons. are involved in the development and maintenance of sexual desire, and are thought to play a key role in the development of sexual dysfunction in older adults.

In addition to its role in sexual function, GnRHR2 has also been shown to be involved in the regulation of anxiety and depression. GnRHR2 has been shown to play a role in the regulation of anxiety and depression by modulating the activity of other nervous system genes. For example, GnRHR2 has been shown to be involved in the regulation of the expression of genes involved in anxiety and depression, such as the genes involved in the regulation of neurotransmitter systems.

GnRHR2 has also been shown to play a role in the regulation of inflammation in the brain. GnRHR2 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha, by modulating the activity of other hormones , such as cortisol. GnRHR2 has also been shown to be involved in the regulation of the production of anti-inflammatory cytokines, such as IL-10, by modulating the activity of other hormones, such as PDGF.

GnRHR2 has also been shown to play a role in the regulation of the development and maintenance of cancer. GnRHR2 has been shown to be involved in the regulation of cell proliferation and survival, and has been implicated in the development and progression of several types of cancer. . For example, GnRHR2 has been shown to be involved in the regulation of the development of neuroblastoma, a type of cancer that is characterized by the proliferation of immature cells in the brain.

Despite its potential as a drug target, GnRHR2 has not yet been studied extensively, and there is a lack of understanding of its full role in the regulation of sexual function, anxiety, and depression. Further research is needed to fully understand the role of GnRHR2 in these processes and to explore its potential as a drug target.

Protein Name: Gonadotropin Releasing Hormone Receptor 2 (pseudogene)

Functions: Putative receptor for gonadotropin releasing hormone II (GnRH II) which is most probably non-functional

The "GNRHR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GNRHR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets